AMINOMINE (100 Caps)

Description

NDC: 53335-714-14

Weight: 4 Oz

AMINOMINE is a targeted blend of 14 L-crystalline amino acids, formulated to nourish the brain’s remarkable capacity for memory and activity over a lifetime. The brain relies on consistent oxygen flow and specific nutrients, which can decline with age due to capillary damage. AMINOMINE supplies amino acids that support the strengthening and repair of aging brain blood vessels, helping to retard physiological degradation and maintain oxygen circulation for optimal function.

This formula features a balanced combination of neurotransmitter precursors, including Tyrosine, Phenylalanine, and Leucine, essential for producing serotonin and dopamine, which are key to memory, focus, and mental acuity. Recent studies with geriatric subjects show that daily amino acid supplementation can improve cognitive symptoms like memory disturbance, fatigue, decision-making, concentration, forgetfulness, and speech difficulties. For those with Alzheimer’s, where amino acid metabolism is often disrupted, AMINOMINE provides foundational support by promoting neurotransmitter balance and vascular health, potentially mitigating disease progression.

AMINOMINE is a registered blend with a National Drug Code from the FDA and is featured in the Physician’s Desk Reference.

It is crafted using U.S. Pharmaceutical Grade Amino Acids without fillers, binders, or coloring agents, and has no reported side effects.

Directions: Take 1-2 capsules daily or as advised by your healthcare provider. Pair with vitamins and minerals; GPD’s MVM (Multivitamin) is recommended.

Key Benefits

• Enhances Memory Function: Boosts neurotransmitter production for better recall and cognition.
• Improves Mental Acuity: Supports focus, decision-making, and reduces fatigue in aging.
• Promotes Brain Circulation: Aids capillary repair for sustained oxygen delivery.

References

• Balch JF, Balch PA. Prescription for Nutritional Healing. Avery Publishing Group; 1997.
• Munro HN, Crim MC, Young VR. In: Shils ME, ed. Modern Nutrition in Health and Disease. Lea & Febiger; 1988.
• DiPasquale MG. Amino Acids and Proteins for the Athlete: The Anabolic Edge. CRC Press; 1997.
• Shils ME, Olson JA, Shike M, Ross AC. Modern Nutrition in Health and Disease. 9th ed. Williams & Wilkins; 1999.
• Werbach MR. Nutritional Influences on Illness. 2nd ed. Third Line Press; 1993.
• Schubert DR, et al. (2008). “Diabetes Link to Alzheimer’s Disease Explained.” Neurobiology of Aging, ScienceDaily.
• Nation DA, et al. (2019). “Cortical and subcortical cerebrovascular resistance in Alzheimer’s disease.” Journal of Alzheimer’s Disease.
• Bell RD, Zlokovic BV. (2009). “Neurovascular mechanisms and blood-brain barrier disruption in Alzheimer’s disease.” Biochimica et Biophysica Acta.
• Owasoyo JO. (1990). “Effects of vitamins and amino acids on the brain.” Nutrition Research.
• Alzheimer’s Association. (2024). “Brain Health and Nutrition.”
• Trachtenberg MC, Blum K. (2016). “Nutritional and genetic factors in addiction recovery.” Journal of Addiction Research & Therapy.
• Mayo Clinic. (2023). “Nutritional Therapy in Substance Use Disorders.”

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.